289 related articles for article (PubMed ID: 36905358)
1. Nanoparticle-Mediated STING Activation for Cancer Immunotherapy.
Li Y; Li X; Yi J; Cao Y; Qin Z; Zhong Z; Yang W
Adv Healthc Mater; 2023 Jul; 12(19):e2300260. PubMed ID: 36905358
[TBL] [Abstract][Full Text] [Related]
2. Nanodelivery of cGAS-STING activators for tumor immunotherapy.
Guo J; Huang L
Trends Pharmacol Sci; 2022 Nov; 43(11):957-972. PubMed ID: 36089410
[TBL] [Abstract][Full Text] [Related]
3. Engineering and Delivery of cGAS-STING Immunomodulators for the Immunotherapy of Cancer and Autoimmune Diseases.
Zhou S; Cheng F; Zhang Y; Su T; Zhu G
Acc Chem Res; 2023 Nov; 56(21):2933-2943. PubMed ID: 37802125
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive elaboration of the cGAS-STING signaling axis in cancer development and immunotherapy.
Zheng J; Mo J; Zhu T; Zhuo W; Yi Y; Hu S; Yin J; Zhang W; Zhou H; Liu Z
Mol Cancer; 2020 Aug; 19(1):133. PubMed ID: 32854711
[TBL] [Abstract][Full Text] [Related]
5. Targeting STING for cancer immunotherapy: From mechanisms to translation.
Huang R; Ning Q; Zhao J; Zhao X; Zeng L; Yi Y; Tang S
Int Immunopharmacol; 2022 Dec; 113(Pt A):109304. PubMed ID: 36252492
[TBL] [Abstract][Full Text] [Related]
6. cGAS-STING signaling in cancer immunity and immunotherapy.
Du H; Xu T; Cui M
Biomed Pharmacother; 2021 Jan; 133():110972. PubMed ID: 33254021
[TBL] [Abstract][Full Text] [Related]
7. The cyclic guanosine monophosphate synthase-stimulator of interferon genes pathway as a potential target for tumor immunotherapy.
Chen R; Liu M; Jiang Q; Meng X; Wei J
Front Immunol; 2023; 14():1121603. PubMed ID: 37153627
[TBL] [Abstract][Full Text] [Related]
8. cGAS/STING cross-talks with cell cycle and potentiates cancer immunotherapy.
Long ZJ; Wang JD; Xu JQ; Lei XX; Liu Q
Mol Ther; 2022 Mar; 30(3):1006-1017. PubMed ID: 35121107
[TBL] [Abstract][Full Text] [Related]
9. cGAS-STING Pathway as the Target of Immunotherapy for Lung Cancer.
Dan Q; Yang Y; Ge H
Curr Cancer Drug Targets; 2023; 23(5):354-362. PubMed ID: 36380440
[TBL] [Abstract][Full Text] [Related]
10. Emerging mechanisms and implications of cGAS-STING signaling in cancer immunotherapy strategies.
Zhang J; Yu S; Peng Q; Wang P; Fang L
Cancer Biol Med; 2024 Jan; 21(1):45-64. PubMed ID: 38172538
[TBL] [Abstract][Full Text] [Related]
11. Insight into the dichotomous regulation of STING activation in immunotherapy.
Hu Z; Yang Y; Fang L; Zhou J; Zhang H
Immunopharmacol Immunotoxicol; 2021 Apr; 43(2):126-137. PubMed ID: 33618600
[TBL] [Abstract][Full Text] [Related]
12. Nanomaterial-mediated modulation of the cGAS-STING signaling pathway for enhanced cancer immunotherapy.
Wang Y; Liu Y; Zhang J; Peng Q; Wang X; Xiao X; Shi K
Acta Biomater; 2024 Mar; 176():51-76. PubMed ID: 38237711
[TBL] [Abstract][Full Text] [Related]
13. Targeting STING in cancer: Challenges and emerging opportunities.
Zhao K; Huang J; Zhao Y; Wang S; Xu J; Yin K
Biochim Biophys Acta Rev Cancer; 2023 Nov; 1878(6):188983. PubMed ID: 37717857
[TBL] [Abstract][Full Text] [Related]
14. Nanoparticle-Mediated STING Agonist Delivery for Enhanced Cancer Immunotherapy.
Zhou Q; Zhou Y; Li T; Ge Z
Macromol Biosci; 2021 Aug; 21(8):e2100133. PubMed ID: 34117839
[TBL] [Abstract][Full Text] [Related]
15. STING activation in cancer immunotherapy.
Su T; Zhang Y; Valerie K; Wang XY; Lin S; Zhu G
Theranostics; 2019; 9(25):7759-7771. PubMed ID: 31695799
[TBL] [Abstract][Full Text] [Related]
16. Medicinal chemistry perspective on cGAS-STING signaling pathway with small molecule inhibitors.
Tian X; Xu F; Zhu Q; Feng Z; Dai W; Zhou Y; You QD; Xu X
Eur J Med Chem; 2022 Dec; 244():114791. PubMed ID: 36206657
[TBL] [Abstract][Full Text] [Related]
17. Hyperbaric oxygen facilitates teniposide-induced cGAS-STING activation to enhance the antitumor efficacy of PD-1 antibody in HCC.
Li K; Gong Y; Qiu D; Tang H; Zhang J; Yuan Z; Huang Y; Qin Y; Ye L; Yang Y
J Immunother Cancer; 2022 Aug; 10(8):. PubMed ID: 36002188
[TBL] [Abstract][Full Text] [Related]
18. Role of the cGAS-STING pathway in cancer development and oncotherapeutic approaches.
Khoo LT; Chen LY
EMBO Rep; 2018 Dec; 19(12):. PubMed ID: 30446584
[TBL] [Abstract][Full Text] [Related]
19. Regulation of cGAS-STING signalling in cancer: Approach for combination therapy.
Vasiyani H; Wadhwa B; Singh R
Biochim Biophys Acta Rev Cancer; 2023 May; 1878(3):188896. PubMed ID: 37088059
[TBL] [Abstract][Full Text] [Related]
20. Differential reinforcement of cGAS-STING pathway-involved immunotherapy by biomineralized bacterial outer membrane-sensitized EBRT and RNT.
Shen M; Guo L; Zhang H; Zheng B; Liu X; Gu J; Yang T; Sun C; Yi X
J Nanobiotechnology; 2024 Jun; 22(1):310. PubMed ID: 38831378
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
